Data Exclusivity Rules Rile Canadian Generics Makers

By Erin Marie Daly (November 14, 2006, 12:00 AM EST) -- A month after Canada changed its patent rules to extend the period of data protection for brand-name drugs, the country's generic drug industry has launched a legal attack on the amendment, arguing that the move will unfairly boost the balance sheets of pharmaceutical giants and deplete the health care system of millions of dollars....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!